These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 15140233)
1. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233 [TBL] [Abstract][Full Text] [Related]
2. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
3. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936 [TBL] [Abstract][Full Text] [Related]
5. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma. Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577 [TBL] [Abstract][Full Text] [Related]
6. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
7. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918 [TBL] [Abstract][Full Text] [Related]
8. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210 [TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma. Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
14. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628 [TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck. Weber A; Wittekind C; Tannapfel A Pathol Res Pract; 2003; 199(6):391-7. PubMed ID: 12924439 [TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082 [TBL] [Abstract][Full Text] [Related]
17. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [TBL] [Abstract][Full Text] [Related]
18. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126 [TBL] [Abstract][Full Text] [Related]
19. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas. Kaune KM; Neumann C; Hallermann C; Haller F; Schön MP; Middel P Exp Dermatol; 2011 Apr; 20(4):331-5. PubMed ID: 21410763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]